@kevinyau.bsky.social GLP1 agonist master Jedi presenting at #ERA25.

💉GLP1 agonist reduce ED visits and hospitalizations!!!

📉Awesome methods. Best of the session:

💊DDP4 for comparison, IPTW, ICES data. Ticking all the right boxes (EPI nerd).

💊Only 40% on SGLT2i!!! We should flozinate more!!!

In the CONFIDENCE trial in persons with chronic kidney disease and type 2 diabetes, combination therapy with finerenone and empagliflozin led to a greater reduction in the urinary albumin-to-creatinine ratio than either drug alone. Full trial results: nej.md/4jEVbbk

#ERA25 #MedSky #Nephrology

New Things We Do For No Reason in JHM: Avoiding IV Contrast in Patients with AKI or CKD.

I am squarely in the "contrast-associated AKI is not real" camp. #NephSky #medsky

#Nephpearls #NephSky

🚨Hey #NephSky!
Welcome to a new #Medsky #Skytorial brought to you by @kireports.bsky.social
Our author is @brianrifkin.bsky.social nephrologist in Hattiesburg, MS
Please check out #KIReportsCommunity educational #blogposts too!

⚠️ The FDA has approved oral iptacopan to treat proteinuria in adults with C3 glomerulopathy. This is the first FDA-approved treatment for C3G. #fda #c3glomerulopathy #c3g #kidneydisease #nephrology #nephsky

Albuminuria in Cardiovascular, Kidney, and Metabolic Disorders: A State-of-the-Art Review 👩‍🔬🥼🧪👨‍🔬 #CardioSky #NephSky #cardiovascular #cardio-renal #metabolicdisorder #KidneyResearch #kidneydisease 👇👇👇

www.ahajournals.org/doi/epub/10....

Among those w/ nonproteinuric CKD, use of RASi is associated w/ fewer CV events & lower mortality risk vs. other antihypertensive meds
#Nephpearls #NephSky

📌 Patients w/ nonproteinuric CKD may benefit from “prioritizing RASI for hypertension management”

👉🏼 pubmed.ncbi.nlm.nih.gov/39087321/

In 10 years, the prevalence of T2DM increased in younger (7.8% vs. 4.5%, p < 0.0001) and older individuals (34% vs. 28.4%, p < 0.0001).
In 10 yrs, incidence of T2DM increased by 120% & 150% in the younger & older individuals, respectively.
pmc.ncbi.nlm.nih.gov/articles/PMC...
@isn-india.bsky.social

Last up is @bhallaresearch.bsky.social on PA

Appalling screening rates despite similar mortality to breast cancer

#ISNWCN #NephSKy

Honored to have been elected as @theisn.org Regional Board Deputy Chair for North America and the Caribbean 2025-27
#ISNWCN 🇮🇳 #WCN25 🇮🇳 #NephSky

Interesting list

10 things nephrologists hope every PCP/Hospitalist knew from @kdjhaveri.bsky.social

www.nephronpower.com/2025/01/top-...

What else would you add?

#NephSky

@nephjc.bsky.social
Check out the lovely VA for tonight’s discussion from Madiha Aziz. #NephJC

Excited to join BlueSky! Looking forward to connecting and sharing insights here. Let’s make this space meaningful. Any recommendations on who to follow? #Kidneys #Kidneysrock

New Blood Pressure Target For Individuals at High Risk

#hypertension
#CardioSky
#MedSky
www.acc.org/Latest-in-Ca...